Awaiting development: Guidance and quality standards
Showing 1 to 5 of 5
| Title | Type |
|---|---|
| Aprocitentan for treating resistant hypertension [TSID10395] | Technology appraisal guidance |
| Baxdrostat for treating uncontrolled or resistant hypertension [ID6623] | Technology appraisal guidance |
| Netarsudil for treating open angle glaucoma or ocular hypertension [ID1078] | Technology appraisal guidance |
| Secondary care management of malignant hypertension | Quality standard |
| Treprostinil diethanolamine for treating pulmonary arterial hypertension [TSID11772] | Technology appraisal guidance |